In London, pharmaceutical stocks weighed on the blue-chip FTSE 100 index after Trump demanded that drug companies lower prices for American consumers. GSK fell 1.2% and AstraZeneca dipped 1.8%.

The NAV total return was short of the 0.8% of the trust's benchmark, the FTSE all-world index. However, the company's share price total return matched it at 0.8%, as the discount of its share price to ...

While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

UK Indices - FTSE 100, FTSE 250, FTSE 350, FTSE All ShareClick on the Index names to view more information.